Correlation Between Ardelyx and Design Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ardelyx and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ardelyx and Design Therapeutics, you can compare the effects of market volatilities on Ardelyx and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Design Therapeutics.

Diversification Opportunities for Ardelyx and Design Therapeutics

-0.4

Correlation Coefficient

Ardelyx  Design Therapeutics

Very good diversification

The 3 months correlation between Ardelyx and Design is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Ardelyx i.e., Ardelyx and Design Therapeutics go up and down completely randomly.

Pair Corralation between Ardelyx and Design Therapeutics

Given the investment horizon of 90 days Ardelyx is expected to generate 0.87 times more return on investment than Design Therapeutics. However, Ardelyx is 1.14 times less risky than Design Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  293.00  in Ardelyx on October 22, 2024 and sell it today you would earn a total of  208.00  from holding Ardelyx or generate 70.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ardelyx  vs.  Design Therapeutics

Ardelyx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Ardelyx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Design Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Design Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Design Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Ardelyx and Design Therapeutics

The main advantage of trading using opposite Ardelyx and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.

The idea behind Ardelyx and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.